Morning-After
Pill Conspiracy FOR
IMMEDIATE RELEASE—March 22, 2005
- Annie Tummino, Lead Plaintiff of Tummino v. Crawford, cell
917-842-5306
- Kelly Mangan, Chair, Florida NOW Young Feminist Task Force,
cell
850-445-4273
- Stephanie Seguin, Gainesville (Fla.) Women's Liberation, cell
352-281-7454
- Erin Mahoney, Chair, New York Reproductive Rights Task Force,
cell
917-842-5306
FEMINISTS DECLARE LESTER CRAWFORD UNFIT FOR FDA COMMISSIONER POST, SUE FDA OVER MORNING-AFTER PILL
WHAT: Feminists suing the FDA oppose nominee at press conference
in
front of
Hyattsville District Court (4990 Rhode Island Ave. Hyattsville, MD)
WHEN: Wednesday, March 23, 5:00pm
PARTICIPANTS: Individual plaintiffs in Tummino v.
Crawford
representing the Morning-After Pill Conspiracy, a national coalition of
feminist organizations which include the New York Reproductive Rights
Task
Force; Redstockings Allies and Veterans, NYC; Gainesville Area (FL)
National
Organization for Women (NOW); Florida NOW Young Feminist Task Force;
Gainesville (FL) Women’s Liberation; University of Florida Campus NOW
Feminists who are suing FDA commissioner-nominee Lester Crawford say he
is
unfit to serve as Commissioner of the FDA as long as he continues to
block
women’s access to the Morning-After Pill, a needed emergency
contraceptive.
In a lawsuit filed by the Center for Reproductive Rights on Jan. 21,
the
plaintiffs allege that the FDA has failed to follow its own procedures
and
statutory and regulatory mandates. According to the FDA’s own advisory
committees, the Morning-After Pill meets all the criteria for an
over-the-counter drug. But Crawford, as acting FDA commissioner,
has
blocked approval. A decision to reject Plan B (TM) for
over-the-counter
sales discriminates against women, the
suit charges.
Reacting to Crawford’s confirmation hearings, lead plaintiff Annie
Tummino said
"Crawford and the FDA have violated the rights of American women by
withholding access to this safe, effective form of birth control.
His
nomination is an insult to the women of the U.S."
Stephanie Seguin, of Gainesville (Fla.) Women’s Liberation, also a
plaintiff,
says that the prescription requirement makes the pill impossible to
use, “When
I needed the pill I had to fight heavy football game traffic to get to
my
school’s infirmary which turned out to be closed. I
gave up trying to get the pill because I didn’t know where else
to go.”
Erin Mahoney, Chair of the New York Reproductive Rights Task Force said
Crawford is unfit to be FDA Commissioner because he has allowed
politics to
trump science. "Lester Crawford has ignored the FDA’s own medical
experts,
more than 70 major health organizations, and the women who need easier
access
to the Morning-After Pill," she said. "This is sexist. We
call on the women of the U.S. to urge rejection of Lester Crawford for
FDA head
until such time as he
stops blocking our access to needed contraceptives."
--MORE--
--ADD 1--
Background:
According
to the New York Times, Senate Democrats questioned Dr. Lester M. Crawford, President Bush's
choice to
lead the Food and Drug Administration,
about why the agency had so far refused to allow over-the-counter sales of the
morning-after pill Plan B.
''What
has disturbed many of us is what appears is political interference in a scientific process,'' said
Senator
Hillary Rodham Clinton, Democrat of New York. ''We rely on the F.D.A.
for
everything we take, and I am hopeful that we will reverse what appears to be a dangerous slide into
political opinion as
opposed to scientific evidence.'' (Gardiner Harris, New York Times,
3/18/05)
The Morning-After Pill (MAP), or "emergency
contraception," is simply a higher dose of regular birth control pills.
It
prevents pregnancy when taken up to 5 days after sex, but it is most
effective
when taken within the first 24 hours. (It is not the same as RU-486,
the
abortion pill.)
Plan B (TM) is manufactured by Barr Laboratories, which applied for
over-the-counter status.
The Journal of the American Medical Association published a UCSF study
on Jan.
5 showing that increased access to the Morning-After Pill doesn’t cause
women
to engage in more risky sex.
The FDA has been quick to get drugs on the market like Vioxx (TM),
which
scientists objected to, but when it comes to drugs that benefit women,
political
pressure trumps medical science.
The Morning After Pill is available without a prescription in 38 other
countries.
The FDA’s own advisory panels voted in December 2003 that the drug is
safe and
voted 23-4 to approve it for over the counter use in the U.S.
More than 2,000 women around the country have signed the Morning-After
Pill
Conspiracy’s pledge promising to break the law (and the prescription
requirement) by giving their MAP to friends whenever they need
it.
Who is the Morning-After Pill Conspiracy? The MAP
Conspiracy is a
coalition of feminist organizations leading the grassroots movement to
make the
Morning-After Pill an over-the-counter drug. The name is a reference to
the
fact that women have to conspire to break the law just to get the
Morning-After
Pill. The FDA’s prescription requirement forces us to rely on friends
who may
have it because we cannot get MAP when the need arises. We started
passing out
the pills publicly in defiance of the prescription requirement on Feb.
15,
2004. Our campaign seeks to highlight the injustice of the prescription
requirement, and we use speak-outs where women speak from their own
experience,
to show that women are the real experts on why women need unrestricted
access
to the Morning-After Pill. We have held speak-outs and handed out MAP
in New
York City; Washington D.C; Rockville, Maryland; and Gainesville, Fla.
More than
2,000 women around the country have signed the pledge to "Give a friend
the Morning-After Pill," defying the prescription requirement. The
pledge
is available online at
www.mapconspiracy.org.
####